ZOETIS INC.

ZTS

Zoetis Inc. (ZTS) is a global leader in animal health, providing a wide range of pharmaceutical, vaccine, and diagnostic products for livestock and companion animals. Established in 1952 and becoming an independent company in 2013, Zoetis develops innovative solutions to improve animal health and well-being, supporting the needs of veterinarians, pet owners, and livestock producers worldwide.

$118.01 -0.62 (-0.52%)
Dividend Yield 1.69%
Payout Frequency Quarterly

Dividend History

Pay DateAmountEx-DateRecord Date
December 2, 2025$0.502025-10-312025-10-31
September 3, 2025$0.502025-07-182025-07-18
June 3, 2025$0.502025-04-212025-04-21
March 4, 2025$0.502025-01-212025-01-21
December 3, 2024$0.432024-10-312024-10-31

Dividends Summary

Company News

2 Magnificent Dividend Stocks to Buy and Hold Forever
The Motley Fool • Prosper Junior Bakiny • November 2, 2025

The article highlights two dividend stocks, AbbVie and Zoetis, as excellent long-term investment options due to their stable business models, consistent revenue generation, and impressive dividend growth track records.

Companion Animal Health Market to Worth USD 61.74 Billion by 2034, Driven by Rising Pet Ownership and Humanization Trends
GlobeNewswire Inc. • Towards Healthcare • October 31, 2025

The global companion animal health market is projected to grow from USD 25.28 billion in 2024 to USD 61.74 billion by 2034, driven by rising pet ownership, pet humanization trends, and advances in veterinary technologies.

Zoetis Beats Wall Street Estimates, Revises 2025 Guidance To Include Tariffs Impact
Benzinga • Vandana Singh • May 6, 2025

Zoetis reported strong Q1 2025 results, beating Wall Street estimates. The company also revised its FY2025 guidance, raising the adjusted EPS range to $6.20-$6.30, above the previous guidance and consensus.

USNA or ZTS: Which Is the Better Value Stock Right Now?
Zacks Investment Research • Zacks Equity Research • June 21, 2024

USNA vs. ZTS: Which Stock Is the Better Value Option?

My Dividend Growth Portfolio: Selling Bio-Pharma And Buying More Big-Tech
Seeking Alpha • Nicholas Ward • May 13, 2024

I have shifted my strategy to focus on quality rather than value and have been buying big-tech stocks. Read more to see a review of my portfolio.

Related Companies